Scientists Test New Gene Therapy for Vision Loss From a Mitochondrial Disease
Researchers funded by the National Institutes of Health have developed a novel mouse model for the vision disorder Leber hereditary optic neuropathy (LHON), and found that they can use gene therapy to improve visual function in the mice. LHON is one of many diseases tied to gene mutations that damage the tiny energy factories that power our cells, called mitochondria.
Language
English
Source: News from NEI - Category: Opthalmology Authors: Jason Source Type: news
More News: Eyes | Gene Therapy | Genetics | Health | Mitochondria | Mitochondrial Disease | National Institutes of Health (NIH) | Neurology | Opthalmology